Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Foggia

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Atherosclerosis|December 17, 2008
Human immunodeficiency virus per se exerts atherogenic effectsUgo Oliviero, Giovanni Bonadies, Valentina Apuzzi, et al.
Journal of Gastroenterology and Hepatology|December 7, 2020
Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world settingNicola Imperatore, Maria Foggia, Marta Patturelli, et al.
Irish Journal of Medical Science|September 25, 2021
Quantitative but not qualitative flavor recognition impairments in COVID-19 patientsImmacolata Cristina Nettore, Elena Cantone, Giuseppe Palatucci, et al.
Infectious Diseases (London, England)|September 5, 2025
Activity of sotrovimab in early clearance of SARS CoV-2 infection in severe immunocompromised patients: results of a prospective, monocentric studyGiulio Viceconte, Antonio Riccardo Buonomo, Emilia Trucillo, et al.
Heliyon|January 30, 2023
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experienceNicola Schiano Moriello, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Frontiers in Medicine|July 8, 2022
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective StudyBiagio Pinchera, Lorenzo Spirito, Antonio Riccardo Buonomo, et al.
Le Infezioni in Medicina|December 9, 2022
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control studyGiulio Viceconte, Andrea Ponsiglione, Antonio Riccardo Buonomo, et al.
International Journal of Environmental Research and Public Health|November 13, 2021
<i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center ExperienceIvan Gentile, Giulio Viceconte, Amedeo Lanzardo, et al.
Journal of Fungi (Basel, Switzerland)|August 25, 2023
Risk Factors for <i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control StudyGiulio Viceconte, Antonio Riccardo Buonomo, Alessia D'Agostino, et al.
Vaccines|December 23, 2022
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19Riccardo Scotto, Amedeo Lanzardo, Antonio Riccardo Buonomo, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Atherosclerosis|December 17, 2008
Human immunodeficiency virus per se exerts atherogenic effectsUgo Oliviero, Giovanni Bonadies, Valentina Apuzzi, et al.
Journal of Gastroenterology and Hepatology|December 7, 2020
Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world settingNicola Imperatore, Maria Foggia, Marta Patturelli, et al.
Irish Journal of Medical Science|September 25, 2021
Quantitative but not qualitative flavor recognition impairments in COVID-19 patientsImmacolata Cristina Nettore, Elena Cantone, Giuseppe Palatucci, et al.
Infectious Diseases (London, England)|September 5, 2025
Activity of sotrovimab in early clearance of SARS CoV-2 infection in severe immunocompromised patients: results of a prospective, monocentric studyGiulio Viceconte, Antonio Riccardo Buonomo, Emilia Trucillo, et al.
Heliyon|January 30, 2023
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experienceNicola Schiano Moriello, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Frontiers in Medicine|July 8, 2022
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective StudyBiagio Pinchera, Lorenzo Spirito, Antonio Riccardo Buonomo, et al.
Le Infezioni in Medicina|December 9, 2022
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control studyGiulio Viceconte, Andrea Ponsiglione, Antonio Riccardo Buonomo, et al.
International Journal of Environmental Research and Public Health|November 13, 2021
<i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center ExperienceIvan Gentile, Giulio Viceconte, Amedeo Lanzardo, et al.
Journal of Fungi (Basel, Switzerland)|August 25, 2023
Risk Factors for <i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control StudyGiulio Viceconte, Antonio Riccardo Buonomo, Alessia D'Agostino, et al.
Vaccines|December 23, 2022
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19Riccardo Scotto, Amedeo Lanzardo, Antonio Riccardo Buonomo, et al.
Pageof 3